Cell motility in chronic lymphocytic leukemia: Defective Rap1 and αLβ2 activation by chemokine

Cancer Research

Volumn 68, Issue 20, 2008, Pages 8429-8436

  Till, Kathleen J ^a   Harris, Robert J ^a   Linford, Andrea ^a   Spiller, David G ^a   Zuzel, Mirko ^a   Cawley, John C ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHALBETA2 INTEGRIN; CHEMOKINE; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; LYMPHOCYTE ANTIGEN; RAP1 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; CELL MIGRATION; CELL MOTILITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIGAND BINDING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFECT; STIMULATION;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; CHEMOKINES; GUANOSINE TRIPHOSPHATE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; LYMPHOCYTES; TELOMERE-BINDING PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 54249089876     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1758     Document Type: Article

References (45)

1. Rai K, Sawitsky A, Cronkite EP, Channa AD, Levy RN, Pasternack BS. Clinical staging for chronic lymphocytic leukemia. Blood 1975;46:219-34.
2. Binet JL, Lepoporier M, Digheiro G, et al. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 1977;40:855-64.
3. Till KJ, Lin K, Zuzel M, Cawley JC. The chemokine receptor CCR7 and α4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood 2002;99:2977-84.
4. Till KJ, Spiller DJ, Harris RJ, Chen H, Zuzel M, Cawley JC. CLL, but not normal, B cells are dependent on autocrine VEGF and α4β1 integrin for chemokine-induced motility on and through endothelium. Blood 2005;105:4813-9.
5. Pittner BT, Morlan BW, Ballman KV, Kay NE, Jelinek DF. Leukemic B cells from CD38 positive, but not CD38 negative B-CLL patients express heightened levels of α4-integrin. Blood 2003;102:2483.
6. Carman CV, Springer TA. Integrin avidity regulation: are changes in affinity and conformation underemphasised. Curr Opin Cell Biol 2003;15:547-56.
7. Constantin G, Majeed M, Giagulli C, et al. Chemokines trigger immediate β2 integrin and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 2000;13:759-69.
8. Laudanna C. Integrin activation under flow: a local affair. Nat Immunol 2005;6:429-30.
9. Beals CR, Edwards AC, Gottshcalk RJ, Kuijpers TW, Staunton DE. CD18 activation epitopes induced by leukocyte activation. J Immunol 2001;167:6113-22.
10. van Koouk Y, Figdor CG. Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr Opin Cell Biol 2000;12:542-7.
11. Stryckmans P, Debusscher L, Collard E. Cell kinetics in chronic lymphocytic leukaemia (CLL). Clin Haematol 1977;6:159-67.
12. Wu Y, Zhong Z, Huber J, et al. Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer. Clin Cancer Res 2006;12:6573-84.
13. O'Connor P. Natalizumab and the role of α4-integrin antagonism in the treatment of multiple sclerosis. Expert Opin Biol Ther 2007;7:123-36.
14. Giblin PA, Lemieux RM. LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics. Curr Pharm Des 2006;12:2771-95.
15. Kamiguti AS, Harris RJ, Slupsky JR, Baker PK, Cawley JC, Zuzel M. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways. Oncogene 2003;22:2272-84.
16. Cabanas C, Hogg N. Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1. Proc Natl Acad Sci U S A 1993;90:5838-42.
17. Keizer GD, Visser W, Vliem M, Figdor CG. A monoclonal antibody (NKI-L16) directed against a unique epitope on the α-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions. J Immunol 1988;140:1393-400.
18. Porter JC, Hogg N. Integrin cross talk: activation of lymphocyte function-associated antigen-1 on human T cells alters α4β1- and α5β1-mediated function. J Cell Biol 1997;138:1437-47.
19. McLeod SJ, Li AHY, Lee RL, Burgess AE, Gold MR. The Rap GTPases regulate B cell migration toward the chemokine stromal cell-derived factor-1 (CXCL12): potential role for Rap2 in promoting B cell migration. J Immunol 2002;169:1365-71.
20. Laudanna C, Kim JY, Constantin G, Butcher EC. Rapid leukocyte activation by chemokines. Immunol Rev 2002;186:37-46.
21. Shamri R, Grabovsky V, Gauget J-M, et al. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium bound chemokines. Nat Immunol 2005;6:497-506.
22. Salas A, Shimaoka M, Kogan AN, Harwook C, von Andrian UH, Springer TA. Rolling adhesion through an extended conformation of integrin αLβ2 and relation to α I and β I-like domains. Immunity 2004;20:393-406.
23. Xie C, Shimaoka M, Xiao H, Schwab P, Klickstein LB, Springer TA. The integrin α-subunit leg extends at a Ca2+-dependent epitope in the thigh/genu interface upon activation. Proc Natl Acad Sci U S A 2004;101:15422-7.
24. Burger JA, Burger M, Kipps TJ. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999;94:3658-67.
25. Jones D, Benjamin RJ, Shahsafaei A, Dorfman DM. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukaemia. Blood 2000;95:627-32.
26. Fagerhom SC, Hilden TJ, Nurmi SM, Gahberg CG. Specific integrin α and β chain phosphorylations regulate LFA-1 activation through affinity-dependent and -independent mechanisms. J Cell Biol 2005;171:705-15.
27. Katagiri K, Maeda A, Shimonaka M, Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat Immunol 2003;4:741-8.
28. Wittchen ES, Van Buul JD, Burridge K, Worthylake RA. Trading spaces: Rap, Rac and Rho as architects of transendothelial migration. Curr Opin Haematol 2005;12:14-21.
29. Hogg N, Smith A, McDowall A, et al. How T cells use LFA-1 to attach and migrate. Immunol Lett 2004;92:51-4.
30. Kinashi T. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 2005;5:546-59.
31. Kinashi T, Katagiri K. Regulation of lymphocyte adhesion and migration by the small GTPase Rap1 and its effector molecule RAPL. Immunol Methods 2004;93:1-5.
32. Kinashi T, Aker M, Sokolovsky-Eisenberg M, et al. LAD-III a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds. Blood 2004;103:1033-6.
33. Tiwari S, Felekkis K, Flies A, Sherr DH, Lerner S. Among circulating hematopoietic cells, B-CLL uniquely express functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis. Blood 2004;103:2661-7.
34. Gold MR, Ingham RJ, McLeod S, et al. Targets of B-cell antigen receptor signalling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signalling pathway and the Rap1 GTPase. Immunol Rev 2000;176:47-68.
35. Damle RN, Ghiotto F, Valetto A, et al. B-cell chronic lymphocytic leukaemia cells express a surface membrane phenotype of activated antigen-experienced B lymphocytes. Blood 2002;99:4087-93.
36. Ghia P, Caligaris-Cappio F. The origin of B-cell chronic lymphocytic leukemia. Semin Oncol 2006;33:150-6.
37. Chan JR, Hyduk SJ, Cybulsky MI. α4β1 integrin/VCAM-1 interaction activated αLβ2 integrin-mediated adhesion to ICAM-1 in human T cells. J Immunol 2000;164:746-53.
38. Rose DM, Liu F, Woodside DG, Han J, Schlaepfer DD, Ginsberg MH. Paxillin binding to the α4 integrin subunit stimulates LFA-1 (integrin αLβ2)-dependent T cell migration by augmenting the activation of focal adhesion kinase/proline-rich tyrosine kinase-2. J Immunol 2003;170:5912-8.
39. Smith A, Stanley P, Jones K, Svensson L, McDowall A, Hogg N. The role of the integrin LFA-1 in T-lymphocyte migration. Immunol Rev 2007;218:135-46.
40. Muller WA. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 2003;6:246-333.
41. Berlin-Rufenach C, Otto F, Mathies M, et al. Lymphocytic migration in lymphocyte function-associated antigen (LFA)-1-deficient mice. J Exp Med 1999;189:1467-78.
42. Miertzschke M, Stanley P, Bunney TD, Rodrigues-Lima F, Hogg N, Katan M. Characterization of interactions of adapter protein RAPL/Nor1B with RAP GTPases and their role in T cell migration. J Biol Chem 2007;282:30629-42.
43. Stevenson F, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B cell receptor. Blood 2004;103:4389-95.
44. Chiorazzi N, Hatzi K, Albesiano E. B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens. Ann N Y Acad Sci 2005;1062:1-12.
45. Ishida I, Su L, Tamura A, et al. Rap1 signal controls B cell receptor repertoire and generation of self-reactive B1a cells. Immunity 2006;24:417-27.